222 related articles for article (PubMed ID: 20538469)
1. 1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.
Salameh BA; Cumpstey I; Sundin A; Leffler H; Nilsson UJ
Bioorg Med Chem; 2010 Jul; 18(14):5367-78. PubMed ID: 20538469
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors.
Tejler J; Skogman F; Leffler H; Nilsson UJ
Carbohydr Res; 2007 Sep; 342(12-13):1869-75. PubMed ID: 17407769
[TBL] [Abstract][Full Text] [Related]
3. Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.
van Hattum H; Branderhorst HM; Moret EE; Nilsson UJ; Leffler H; Pieters RJ
J Med Chem; 2013 Feb; 56(3):1350-4. PubMed ID: 23281927
[TBL] [Abstract][Full Text] [Related]
4. Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3.
Tejler J; Salameh B; Leffler H; Nilsson UJ
Org Biomol Chem; 2009 Oct; 7(19):3982-90. PubMed ID: 19763301
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of new thiodigalactoside-based chemical probes to label galectin-3.
van Scherpenzeel M; Moret EE; Ballell L; Liskamp RM; Nilsson UJ; Leffler H; Pieters RJ
Chembiochem; 2009 Jul; 10(10):1724-33. PubMed ID: 19492387
[TBL] [Abstract][Full Text] [Related]
6. 3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3.
Salameh BA; Leffler H; Nilsson UJ
Bioorg Med Chem Lett; 2005 Jul; 15(14):3344-6. PubMed ID: 15963723
[TBL] [Abstract][Full Text] [Related]
7. C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions.
Cumpstey I; Sundin A; Leffler H; Nilsson UJ
Angew Chem Int Ed Engl; 2005 Aug; 44(32):5110-2. PubMed ID: 16007713
[No Abstract] [Full Text] [Related]
8. A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model.
Rajput VK; MacKinnon A; Mandal S; Collins P; Blanchard H; Leffler H; Sethi T; Schambye H; Mukhopadhyay B; Nilsson UJ
J Med Chem; 2016 Sep; 59(17):8141-7. PubMed ID: 27500311
[TBL] [Abstract][Full Text] [Related]
9. Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity.
Peterson K; Kumar R; Stenström O; Verma P; Verma PR; Håkansson M; Kahl-Knutsson B; Zetterberg F; Leffler H; Akke M; Logan DT; Nilsson UJ
J Med Chem; 2018 Feb; 61(3):1164-1175. PubMed ID: 29284090
[TBL] [Abstract][Full Text] [Related]
10. Efficient synthesis of a galectin inhibitor clinical candidate (TD139) using a Payne rearrangement/azidation reaction cascade.
St-Gelais J; Denavit V; Giguère D
Org Biomol Chem; 2020 May; 18(20):3903-3907. PubMed ID: 32400847
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives.
Wuest F; Tang X; Kniess T; Pietzsch J; Suresh M
Bioorg Med Chem; 2009 Feb; 17(3):1146-51. PubMed ID: 19157881
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and antimicrobial activity of some substituted 1,2,3-triazoles.
Holla BS; Mahalinga M; Karthikeyan MS; Poojary B; Akberali PM; Kumari NS
Eur J Med Chem; 2005 Nov; 40(11):1173-8. PubMed ID: 15979767
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate triazoles and isoxazoles as inhibitors of galectins-1 and -3.
Giguère D; Patnam R; Bellefleur MA; St-Pierre C; Sato S; Roy R
Chem Commun (Camb); 2006 Jun; (22):2379-81. PubMed ID: 16733586
[TBL] [Abstract][Full Text] [Related]
14. Thiodigalactoside-Bovine Serum Albumin Conjugates as High-Potency Inhibitors of Galectin-3: An Outstanding Example of Multivalent Presentation of Small Molecule Inhibitors.
Zhang H; Laaf D; Elling L; Pieters RJ
Bioconjug Chem; 2018 Apr; 29(4):1266-1275. PubMed ID: 29474087
[TBL] [Abstract][Full Text] [Related]
15. Thioureido N-acetyllactosamine derivatives as potent galectin-7 and 9N inhibitors.
Salameh BA; Sundin A; Leffler H; Nilsson UJ
Bioorg Med Chem; 2006 Feb; 14(4):1215-20. PubMed ID: 16242339
[TBL] [Abstract][Full Text] [Related]
16. Investigation into the feasibility of thioditaloside as a novel scaffold for galectin-3-specific inhibitors.
Bum-Erdene K; Gagarinov IA; Collins PM; Winger M; Pearson AG; Wilson JC; Leffler H; Nilsson UJ; Grice ID; Blanchard H
Chembiochem; 2013 Jul; 14(11):1331-42. PubMed ID: 23864426
[TBL] [Abstract][Full Text] [Related]
17. Arginine binding motifs: design and synthesis of galactose-derived arginine tweezers as galectin-3 inhibitors.
Oberg CT; Leffler H; Nilsson UJ
J Med Chem; 2008 Apr; 51(7):2297-301. PubMed ID: 18318467
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Yu S; Chai X; Hu H; Yan Y; Guan Z; Zou Y; Sun Q; Wu Q
Eur J Med Chem; 2010 Oct; 45(10):4435-45. PubMed ID: 20675019
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions.
McCarroll AJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF
Org Biomol Chem; 2010 May; 8(9):2078-84. PubMed ID: 20401384
[TBL] [Abstract][Full Text] [Related]
20. Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells.
Delaine T; Cumpstey I; Ingrassia L; Le Mercier M; Okechukwu P; Leffler H; Kiss R; Nilsson UJ
J Med Chem; 2008 Dec; 51(24):8109-14. PubMed ID: 19053747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
